Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
55 Cards in this Set
- Front
- Back
|
Dose for Breast Treatment
|
180 cGy / 5040 cGy + 1000-2000 cGy Boost with Electrons, Brachytherapy, or Photons
|
|
|
Total Dose for Supraclavicular and Posterior Axillary Boost Fields
|
5040 cGy
|
|
|
Fields Treated for Breast Cancer
|
tangents only unless lower axillary nodes are involved
|
|
|
Field Borders for Breast Treatment
|
-1st or 2nd intercostal space
-1-2 cm inferior to breast tissue -sternal region based on intramammary nodes -1-2 cm lateral of breast tissue or midaxillary line |
|
|
Energy for Breast Treatment
|
4-6 MV
|
|
|
Amount of Lung in Breast Fields
|
less than 3 cm
|
|
|
Dose for Moderately or Poorly Differentiated Tumors
|
200 cGy / 6000-6500 cGy for A1, A2, B1, B2, or C tumors
|
|
|
Energy for Prostate Fields
|
10 MeV or higher
|
|
|
Fields for Prostate Cancer
|
6-8 fields
|
|
|
Bladder Instructions for Prostate Cancer Treatment
|
full bladder
|
|
|
Field Borders for Prostate Treatment
|
Whole Pelvis:
-L5-S1 -tip of ischial tuberosity -2 cm past the pelvic rim -mid-pubic symphysis -rectum |
|
|
Source and Dose for Brachytherapy Prostate Boost
|
I-125 - 11000 cGy
Pd-103 - 9000 cGy |
|
|
Total Dose for External Beam Radiation Prostate Boost
|
4500-5000 cGy
|
|
|
Source and Dose for HDR Prostate Boost
|
Ir-192 - 300-400 cGy x 4 over 40 hours or 950 cGy x 2 over 2 weeks
|
|
|
Dose for Prostate Cancer
|
180-200 cGy / 7000-7500 cGy
|
|
|
Total Dose for Postop Prostate Cancer If Extension is Found During Surgery
|
6000-6500 cGy
|
|
|
Total Dose with Recurrent Prostate Cancer
|
6500-7500 cGy with higher morbidity
|
|
|
Source and Total Dose for Prostate Brachytherapy Implants
|
-Au-198 or I-125 to 14400 cGy
-Pd-103 to 12500 cGy |
|
|
Indications for Using Prostate Brachytherapy Implants
|
well-defined, early cancers
|
|
|
Dose for Treating Gynecomastia
|
400 cGy / 1200 cGy prior to the start of hormonal therapy
|
|
|
Dose at Which Breast Erythema Usually Begins
|
3000 cGy
|
|
|
Dose at Which Sore Throat Usually Begins
|
2000-3000 cGy
|
|
|
Dose at Which Fatigue Usually Occurs
|
peaks at 3600 cGy and resolves within 3 weeks of the end of treatment
|
|
|
Dose at Which Bladder Side Effects Usually Occur
|
4-5 weeks after starting treatment and resolve 3-4 weeks of the end of treatment
|
|
|
Dose for Stage I Seminoma
|
125-166 cGy / 2500 cGy
|
|
|
Field Borders for Seminoma Treatment
|
-T-10
-top of obturator foramina -10-12 cm along midline |
|
|
Dose for Stage IIA Seminomas
|
125-166 cGy / 2500 cGy + 500-1000 cGy boost to areas of known disease
|
|
|
Dose for Stage IIB and IIC Seminomas
|
125-166 cGy / 2500 cGy + 500-1000 cGy boost to areas of known disease + 1000-1500 cGy boost + left supraclavicular field
|
|
|
Dose for Malignant Testicular Lymphomas
|
160 cGy / 3000-4000 cGy
|
|
|
Dose for Bowen's Disease
|
200 / 4500-5000 cGy
|
|
|
Total Dose for Brachytherapy Treatment of Bowen's Disease
|
6000-6500 cGy at the surface over 6-7 days
|
|
|
Dose for Penile Cancer
|
250-350 cGy / 5500-6000 cGy with bolus
|
|
|
Dose to Lymph Nodes When Treating Penile Cancer
|
5000 cGy
|
|
|
Lymph Node Chains Treated for Penile Cancer
|
-inguinal lymph nodes
-external iliac lymph nodes -hypogastric lymph nodes |
|
|
Dose to Palpable Lymph Nodes When Treating Penile Cancer
|
7000 cGy
|
|
|
Dose When Treating Post-op Kidney and Ureter Cancers
|
200 cGy / 5000 cGy
|
|
|
Energy for Kidney and Ureter Fields
|
10 MeV or higher
|
|
|
Indications for Radiation Treatment of Kidney and Ureter Cancers
|
-preop
-postop -palliative |
|
|
Total Dose for Kidney and Ureter Cancers
|
4500 cGy
|
|
|
Dose for Pre-op Kidney and Ureter Cancers
|
200 cGy / 2000-3000 cGy
|
|
|
Dose for Inoperable Kidney and Ureter Cancers
|
180 cGy / 5040 cGy + 540 cGy boost
|
|
|
Dose-Limiting Structures When Treating Kidney and Ureter Cancers
|
-spinal cord
-bowel -liver |
|
|
Tolerance Dose of Liver
|
no more than 30% of liver treated above 3600 cGy
|
|
|
Tolerance Dose When Irradiating Both Kidneys
|
total dose below 2000 cGy, preferably below 1500 cGy to avoid radiation nephropathy
|
|
|
Dose for Bladder Cancers at Risk of Pelvic Recurrence Treated Pre-op
|
180 cGy / 4500-5000 cGy to include the pelvic lymph nodes
|
|
|
Dose for Bladder Cancers Delivered During Surgery
|
350 cGy / 1050 cGy to allow for possible post-op treatment
|
|
|
Dose for Bladder Cancers Treated Post-op
|
180 cGy / 5040 cGy limited by toxicity
|
|
|
Field Borders for Bladder Cancer Treatment
|
-L-5
-inferior obturator foramen -2 cm lateral to bony pelvis -anterior symphysis -1.5 cm posterior to the bladder |
|
|
Dose for Bladder Cancers
|
180 cGy / 5040 cGy + 960-1460 boost
|
|
|
Tolerance Dose of Posterior Rectosigmoid Colon
|
6000 cGy
|
|
|
Tolerance Dose of Femoral Head and Neck
|
4500 cGy
|
|
|
Indications for Brachtherapy Treatment of Bladder Cancers
|
single plane implants irradiate 1 cm thickness, limiting use to superficial lesions
|
|
|
Tolerance Dose of Partial Bladder
|
6700-7000 cGy
|
|
|
Tolerance Dose of Whole Bladder
|
5000-6000 cGy
|
|
|
Dose for Bladder Cancers palliative treatment
|
300 cGy / 3000 cGy
|
